Who is sponsoring NCT06057285?

NCT06057285 is sponsored by National Cheng-Kung University Hospital.

What condition does NCT06057285 study?

NCT06057285 studies ACLs Learning.

Is NCT06057285 still recruiting?

NCT06057285 is currently completed. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT06057285

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of an Augmented Reality Application Developed for ACLs Training on the Knowledge and Skill Levels of Nurses

Completed NA Last updated 28 September 2023

What this trial tests

NA trial testing An ACLs cart training course was developed using augmented reality (AR) technologies in ACLs Learning in 102 participants. Completed in 27 December 2021.

Timeline

5 August 2021

Primary endpoint
27 December 2021

27 December 2021

Quick facts

Lead sponsor	National Cheng-Kung University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	102
Start date	5 August 2021
Primary completion	27 December 2021
Estimated completion	27 December 2021
Sites	1 location across Taiwan

Drugs / interventions tested

An ACLs cart training course was developed using augmented reality (AR) technologies

Conditions studied

ACLs Learning — all drugs for ACLs Learning →

Sponsor

National Cheng-Kung University Hospital

Who can join

Adults 22 to 60, any sex, with ACLs Learning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Having Advanced Cardiac Life Support (ACLs) skills is essential for nurses. During the COVID-19 pandemic, augmented reality (AR) technologies were incorporated into medical education to increase learning motivation and accessibility. Objectives: To determine whether using augmented reality for educational applications can significantly improve first aid cart learning, learning motivation, cognitive load, and system usability among nurses in ACLs training of nurses. Design: The present study was a quasi-experiment study. Settings: The research setting was a medical center in southern Taiwan Participants: In total, 102 nurses completed the course, with 43 nurses in the AR group and 59 nurses in the control group. Methods: An ACLs cart training course was developed using augmented reality (AR) technologies in the first stage. However, the efficacy of the developed ACLs training course was evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nurses' Knowledge and Skills After Use of an Augmented Reality App for Advanced Cardiac Life Support Training: Randomized Controlled Trial.
Sun WN, Hsieh MC, Wang WF. · · 2024 · cited 5× · PMID 39636667 · DOI 10.2196/57327

Verify or expand the search:

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06057285 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06057285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing